Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Barbara Eichhorst, Christian Buske(Helmholtz Zentrum München), Emili Montserrat(TiGenix (Spain)), Tadeusz Robak(Medical University of Lodz), Paolo Ghia(Vita-Salute San Raffaele University), Michael Hallek(University of Cologne), Peter Hillmen(Leeds Teaching Hospitals NHS Trust)
Annals of Oncology
August 27, 2015
10.1093/annonc/mdv303
Cited by 604

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k